Detalhe da pesquisa
1.
Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling.
Diabetologia
; 64(12): 2773-2778, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34505161
2.
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice.
Mol Metab
; 63: 101533, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809773
3.
Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase.
Drug Metab Dispos
; 38(11): 1944-53, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20709939
4.
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.
Clin Pharmacokinet
; 55(6): 657-72, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26597252
5.
A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.
Eur J Clin Pharmacol
; 58(10): 683-8, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12610745